The safety, effectiveness and cost‐effectiveness of cytisine in achieving six‐month continuous smoking abstinence in tuberculosis patients—protocol for a double‐blind, placebo‐controlled randomized trial

BACKGROUND AND AIMS: Tuberculosis (TB) patients who quit smoking have much better disease outcomes than those who continue to smoke. In general populations, behavioural support combined with pharmacotherapy is the most effective strategy in helping people to quit. However, there is no evidence for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogar, Omara, Barua, Deepa, Boeckmann, Melanie, Elsey, Helen, Fatima, Razia, Gabe, Rhian, Huque, Rumana, Keding, Ada, Khan, Amina, Kotz, Daniel, Kralikova, Eva, Newell, James N., Nohavova, Iveta, Parrott, Steve, Readshaw, Anne, Renwick, Lottie, Sheikh, Aziz, Siddiqi, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099220/
https://www.ncbi.nlm.nih.gov/pubmed/29676824
http://dx.doi.org/10.1111/add.14242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099220/
https://www.ncbi.nlm.nih.gov/pubmed/29676824
http://dx.doi.org/10.1111/add.14242

Ejemplares similares